Literature DB >> 9310169

Detection of impaired fatty acid metabolism in right ventricular hypertrophy: assessment by I-123 beta-methyl iodophenyl pentadecanoic acid (BMIPP) myocardial single-photon emission computed tomography.

Y Kim1, H Goto, K Kobayashi, Y Sawada, Y Miyake, G Fujiwara, H Chiba, T Okada, T Nishimura.   

Abstract

Fatty acid metabolism has been reported to be impaired earlier than myocardial blood flow in left ventricular hypertrophic myocardium, e.g., in hypertrophic cardiomyopathy or hypertensive heart disease. The purpose of this study was to determine whether impaired fatty acid metabolism also occurs in right ventricular (RV) hypertrophy. The subjects consisted of 6 patients with chronic obstructive pulmonary disease, 4 with primary pulmonary hypertension, 2 each with refractory pulmonary tuberculosis, tricuspid insufficiency, pulmonary embolism, 1 each with atrial septal defect, ventricular septal defect (Eisenmenger complex), Ebstein anomaly, and endocardial defect, and 7 healthy controls. SPECT imaging with Tl-201 (Tl) and I-123 beta-methyliodophenyl pentadecanoic acid (BMIPP), and Tc-99m RBC first pass and gated blood pool scintigraphy were performed. Based on Tl planar images, the subjects were classified into 3 groups: 7 patients with no RV visualization (Group A), 11 with moderate RV visualization (Group B) and 9 with marked RV visualization (Group C). As a semi-quantitative evaluation by Tl myocardial SPECT, 3 regions in 3 representative short axial images were divided into 9 segments, each of which was graded from 0 to +3, and their sum was calculated as the RV score. The right ventricular ejection fraction (RVEF) and the left ventricular ejection fraction were obtained by Tc-99m RBC cardiac scintigraphy. The groups with marked visualization of the right ventricle had lower RVEF (p < 0.01), and there was a good correlation between the RVEF and the RV score with both Tl and BMIPP (Tl: r = -0.79, BMIPP: r = -0.70). Although a good correlation was demonstrated between the RV score with Tl and BMIPP in Groups A and B (r = 0.86, p < 0.001), in Group C, in which there was marked RV T1 visualization, the RV score with BMIPP was significantly smaller than with Tl (BMIPP vs. Tl: 11.5 +/- 3.7 vs. 16.4 +/- 3.8, p < 0.01). These findings suggest that impaired fatty acid metabolism may exist in severely hypertrophic right ventricle due to RV overload.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9310169     DOI: 10.1007/BF03164765

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  13 in total

Review 1.  Future aspects of BMIPP.

Authors:  N Tamaki; K Morita; E Tsukamoto; Y Kawai
Journal:  Int J Card Imaging       Date:  1999-02

2.  Correct interpretation of a myocardial perfusion SPECT study in a patient with Ebstein's anomaly through recognition of septal artifact.

Authors:  Gabriel B Grossman; Raghuveer K Halkar; Wendy Book; Angela Hunsche; Cesar A Santana; Ernest V Garcia
Journal:  J Nucl Cardiol       Date:  2003 Sep-Oct       Impact factor: 5.952

3.  Assessment of right ventricular metabolism: An emerging tool for monitoring pulmonary artery hypertension.

Authors:  Attila Feher; Albert J Sinusas
Journal:  J Nucl Cardiol       Date:  2016-11-18       Impact factor: 5.952

4.  Severe pulmonary hypertension is associated with altered right ventricle metabolic substrate uptake.

Authors:  Brian B Graham; Rahul Kumar; Claudia Mickael; Linda Sanders; Liya Gebreab; Kendra M Huber; Mario Perez; Peter Smith-Jones; Natalie J Serkova; Rubin M Tuder
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-06-26       Impact factor: 5.464

Review 5.  Fatty acid metabolism in pulmonary arterial hypertension: role in right ventricular dysfunction and hypertrophy.

Authors:  Megha Talati; Anna Hemnes
Journal:  Pulm Circ       Date:  2015-06       Impact factor: 3.017

Review 6.  Mitochondrial metabolic adaptation in right ventricular hypertrophy and failure.

Authors:  Lin Piao; Glenn Marsboom; Stephen L Archer
Journal:  J Mol Med (Berl)       Date:  2010-09-04       Impact factor: 4.599

7.  Metabolic gene remodeling and mitochondrial dysfunction in failing right ventricular hypertrophy secondary to pulmonary arterial hypertension.

Authors:  Jose Gomez-Arroyo; Shiro Mizuno; Karol Szczepanek; Benjamin Van Tassell; Ramesh Natarajan; Cristobal G dos Remedios; Jennifer I Drake; Laszlo Farkas; Donatas Kraskauskas; Dayanjan S Wijesinghe; Charles E Chalfant; John Bigbee; Antonio Abbate; Edward J Lesnefsky; Harm J Bogaard; Norbert F Voelkel
Journal:  Circ Heart Fail       Date:  2012-11-14       Impact factor: 8.790

Review 8.  Metabolism of the right ventricle and the response to hypertrophy and failure.

Authors:  S Elissa Altin; P Christian Schulze
Journal:  Prog Cardiovasc Dis       Date:  2012 Sep-Oct       Impact factor: 8.194

9.  Mechanisms of Lipid Accumulation in the Bone Morphogenetic Protein Receptor Type 2 Mutant Right Ventricle.

Authors:  Megha H Talati; Evan L Brittain; Joshua P Fessel; Niki Penner; James Atkinson; Mitch Funke; Carrie Grueter; W Gray Jerome; Michael Freeman; John H Newman; James West; Anna R Hemnes
Journal:  Am J Respir Crit Care Med       Date:  2016-09-15       Impact factor: 21.405

Review 10.  Metabolism in Pulmonary Hypertension.

Authors:  Weiling Xu; Allison J Janocha; Serpil C Erzurum
Journal:  Annu Rev Physiol       Date:  2021-02-10       Impact factor: 19.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.